Zobrazeno 1 - 10
of 42
pro vyhledávání: '"Jennifer L Proctor"'
Autor:
Joseph W. Palmer, Melissa L. Harris, Zoya T Anderson, Dezhi Wang, Andrzej T. Slominski, Misgana I. Idris, Jennifer L. Proctor, Adam E. Martin
Neuropeptide Y (NPY) is a pleiotropic peptide produced in the central nervous system and peripheral organs. Despite conjectures that NPY may have a role in skin physiology and pathology, the effects of NPY in this organ remain poorly understood. We r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::790b426f5d83f292ab2cc81b3f83e0d0
https://doi.org/10.21203/rs.3.rs-944199/v1
https://doi.org/10.21203/rs.3.rs-944199/v1
Autor:
Marisa O Peluso, Veronica T Campbell, Joseph A Harari, Thomas T Tibbitts, Jennifer L Proctor, Nigel Whitebread, James M Conley, Kerry F White, Jeffery L Kutok, Margaret A Read, Karen McGovern, Kerrie L Faia
Publikováno v:
PLoS ONE, Vol 9, Iss 3, p e90534 (2014)
A requisite step for canonical Hedgehog (Hh) pathway activation by Sonic Hedgehog (Shh) ligand is accumulation of Smoothened (Smo) to the primary cilium (PC). Activation of the Hh pathway has been implicated in a broad range of cancers, and several S
Externí odkaz:
https://doaj.org/article/b3435ef7823e4fa0b69c0b4bca9c80e8
Autor:
Christopher K McCann, Whitfield B Growdon, Kashmira Kulkarni-Datar, Michael D Curley, Anne M Friel, Jennifer L Proctor, Hana Sheikh, Igor Deyneko, Jeanne A Ferguson, Vinod Vathipadiekal, Michael J Birrer, Darrell R Borger, Gayatry Mohapatra, Lawrence R Zukerberg, Rosemary Foster, John R Macdougall, Bo R Rueda
Publikováno v:
PLoS ONE, Vol 6, Iss 11, p e28077 (2011)
Recent evidence links aberrant activation of Hedgehog (Hh) signaling with the pathogenesis of several cancers including medulloblastoma, basal cell, small cell lung, pancreatic, prostate and ovarian. This investigation was designed to determine if in
Externí odkaz:
https://doaj.org/article/4e6a983d320640afaf3099882befd611
Autor:
Oliver Mikse, Tahirih L. Lamothe, Lisa M Olson, Nidhi Jain, Jennifer L. Proctor, Ryan Knihtila, Sean McDonough, John C. Davis, Anthony E. Boitano, Rahul Palchaudhuri, Michael P. Cooke, Ganapathy N. Sarma, Bradley R. Pearse, Prashant raj Bhattarai, Leanne Lanieri, Junia Dushime, Kellie Latimer
Publikováno v:
Transplantation and Cellular Therapy. 27:S49-S50
Autor:
Ryan Knihtila, Michael P. Cooke, Tahirih L. Lamothe, Leanne Lanieri, Sean McDonough, Anthony E. Boitano, Prashant raj Bhattarai, John C. Davis, Rahul Palchaudhuri, Junia Dushime, Jennifer L. Proctor, Oliver Miske, Nidhi Jain, Ganapathy N. Sarma, Bradley R. Pearse, Kellie Latimer
Publikováno v:
Blood. 136:47-48
Hematopoietic stem cell transplant (HSCT) can be a highly effective, and often curative, treatment for patients with AML. At present, myeloablative conditioning (MAC) regimens are associated with severe acute and long-term toxicities. A subset of tra
Autor:
Geoff O Gillard, Jennifer L Proctor, Sharon L. Hyzy, Catherine Rhee, Elizabeth W. Scadden, Matthias Nahrendorf, David T. Scadden, Karin Gustafsson, Vanessa Frodermann, Michael P. Cooke, Anthony E. Boitano, Rahul Palchaudhuri
Publikováno v:
Blood. 136:34-35
Cardiovascular disease (CVD) is the leading cause of death worldwide. Recently, age-related clonal hematopoiesis (CH) has been recognized as a risk factor for CVD of comparable magnitude to smoking, hypertension and hypercholesteremia. While these ot
Autor:
Rahul Palchaudhuri, Junia Dushime, Jason Neale, Ganapathy N. Sarma, Bradley R. Pearse, Melissa L. Brooks, Charlotte Mcdonagh, Jennifer L. Proctor, Anthony E. Boitano, Tahirih L. Lamothe, Ryan Knihtila, Nidhi Jain, Rajiv Panwar, Qing Li, Sean McDonough, John C. Davis, Michael P. Cooke, Lena Kien, Kellie Latimer
Publikováno v:
Biology of Blood and Marrow Transplantation. 26:S35-S36
Current approaches to conditioning prior to transplant and gene therapy employ non-specific genotoxic agents that are associated with severe acute and long-term toxicities. Consequently, many transplant eligible patients either refuse transplant or r
Autor:
Rahul Palchaudhuri, Ganapathy N. Sarma, Bradley R. Pearse, Tahirih L. Lamothe, Bruce R. Blazar, John C. Davis, Geoffrey O. Gillard, Katelyn J. Hammond, Anthony E. Boitano, Asim Saha, Charlotte Mcdonagh, Jennifer L. Proctor, Michael P. Cooke, Sharon L. Hyzy, Nicholas M. Clark, Hans-Peter Kiem, John E. Wagner
Publikováno v:
Transplantation and Cellular Therapy. 27:S217
Autor:
Nicholas M. Clark, Hans-Peter Kiem, Anthony E. Boitano, Jennifer L. Proctor, Katelyn J. Hammond, Charlotte Mcdonagh, Anjali Bhat, Geoff O Gillard, Rahul Palchaudhuri, Tahirih L. Lamothe, Ganapathy N. Sarma, Sharon L. Hyzy, Bradley R. Pearse, Bruce R. Blazar, John C. Davis, John E. Wagner, Michael P. Cooke, Asim Saha
Publikováno v:
Blood. 136:31-31
Introduction Allogeneic hematopoietic stem cell transplant (Allo-HSCT) is a potentially curative treatment for malignant and non-malignant blood disorders. However, current conditioning regimens limit the use of this curative procedure in many eligib
Autor:
Jennifer L Proctor, Vanessa Frodermann, Rahul Palchaudhuri, Michael Cook, Karin Gustafsson, Geoff O Gillard, Matthias Nahrendorf, Tony Boitano, David T. Scadden, Catherine Rhee
Publikováno v:
Experimental Hematology. 88:S32
Clonal hematopoiesis (CH) is an age-related phenomenon linked to increases in cardiac mortality, all-cause mortality and myeloid malignancies. The magnitude of risk rivals that of known risk factors like high cholesterol or hypertension. Unlike those